The combination of ingredients in Signal is designed to promote metabolic health, whereas Basis is formulated to target overall cellular aging and DNA maintenance. As metabolic aging is tightly correlated with general aging, there is overlap in the downstream effects of the ingredients in Signal and Basis, and this is reflected in the principal ingredient in both products. As declining NAD+ levels are directly related to general aging and metabolic dysregulation, both Signal and Basis provide an NAD+ precursor molecule to target this decline–Signal contains NMN and Basis contains NR. There is some exciting, early evidence for potential tissue-specificity between the two different NAD+ precursors, as well as varied benefits, suggesting that one precursor may be more dominant in certain tissues than the other. More studies are needed to support this possibility.
In addition to NAD+ precursors, both products provide ingredients that activate sirtuins–a family of enzymes that play a critical role in aging and metabolism. Signal contains Elysium’s SIRT3 Activation Complex, which activates sirtuin 3 (SIRT3), a sirtuin that resides in mitochondria and has been shown to be involved in maintaining mitochondrial health and the generation of new mitochondria. Basis, on the other hand, contains an ingredient that activates sirtuin 1 (SIRT1). Unlike SIRT3, SIRT1 resides mainly in the nucleus and plays an important role in regulating gene expression and histone modification, pointing to a more complex role for this enzyme in modulating a wide array of processes involved in cellular housekeeping, including DNA maintenance. The SIRT1 activator in Basis has also been shown to exhibit antioxidant properties.